Revenue Growth - Consolidated revenues before reimbursements increased by 51.7 million, or 9.9%, for the six months ended June 30, 2022, compared to the same periods in 2021 [112]. - Total revenues, including reimbursements, reached 276.5 million in the same period of 2021 [113]. - Revenues before reimbursements for the three months ended June 30, 2022, were 267,457,000 in 2021, representing a growth of 9.7% [115]. - Total revenues for the three months ended June 30, 2022, were 276.5 million in the same period of 2021 [131]. - Revenues before reimbursements for the six months ended June 30, 2022, totaled 112.5 million in the same period of 2021 [137]. - For the six months ended June 30, 2022, revenues before reimbursements totaled 177.7 million in the same period of 2021 [149]. Segment Performance - Revenues from the North America Loss Adjusting segment increased by 17.0% to 130.2 million for the six months ended June 30, 2022 [113]. - International Operations segment revenues increased by 2.7% to 183.0 million for the six months ended June 30, 2022 [113]. - Broadspire segment revenues rose by 5.5% to 156.6 million for the six months ended June 30, 2022 [113]. - Platform Solutions segment revenues increased by 21.9% to 102.6 million for the six months ended June 30, 2022 [113]. - The International Operations segment reported an operating loss of 2.1 million, or 2.3% in Q2 2021 [144]. Case Volume and Activity - The company experienced a 15.5% increase in cases received for the three months ended June 30, 2022, and a 16.4% increase for the six months ended June 30, 2022, compared to the prior year [112]. - Total Crawford cases received increased by 15.5% to 480,706 for the three months ended June 30, 2022, compared to 416,207 in the same period of 2021 [115]. - The North America Loss Adjusting segment experienced a 19.7% increase in case volumes for Q2 2022, with a total of 76,419 cases received compared to 63,818 in Q2 2021 [139]. - The International Operations segment experienced an 18.6% increase in unit volume, measured by cases received, for Q2 2022 compared to Q2 2021 [151]. - Cases received increased by 18.6% and 24.2% for the three and six months ended June 30, 2022, compared to the same periods in 2021 [154]. Expenses and Profitability - Costs of services provided increased by 6.7 million, or 11.5%, for the three months ended June 30, 2022, compared to the prior year [115]. - Direct expenses for Q2 2022 were 44.9 million in Q2 2021, leading to a gross profit of 5.8 million for the three months ended June 30, 2022, compared to 6.2 million, or 2.3%, for the three months ended June 30, 2022, and 5.3 million, for Q2 2022 compared to Q2 2021 [149]. Corporate and Financial Metrics - The effective income tax rate for the three months ended June 30, 2022, increased to 32.2% compared to 23.3% for the same period in 2021, primarily due to losses in certain international operations [178]. - Corporate interest expense for the three months ended June 30, 2022, totaled 1.5 million in the same period of 2021 [179]. - Cash used in operating activities was 10.5 million provided by operating activities in the same period of 2021 [187]. - Cash used in investing activities was 11.8 million in the same period of 2021 [188]. - At June 30, 2022, the working capital balance was approximately 22.8 million from December 31, 2021 [185].
Crawford(CRD_B) - 2022 Q2 - Quarterly Report